| ¿µ¹® | electronic medical record(EMR) | ÇÑ±Û | ÀüÀÚÀǹ«±â·Ï |
|---|---|---|---|
| ¼³¸í | Àǻ簡 Á¾ÀÌ ´ë½Å ÄÄÇ»ÅÍ¿¡ Á÷Á¢ ȯÀÚÀÇ ÀÓ»óÁ¤º¸¸¦ ÀÔ·ÂÇϸé À̸¦ µ¥ÀÌÅͺ£À̽ºÈÇÏ¿© »õ·Î¿î Á¤º¸·Î °¡°ø-»ý¼ºÇÏ´Â ÀÇ·áÁ¤º¸½Ã½ºÅÛ. ȯÀÚÀÇ Áø·á±â·ÏÀ» ã¾Æ Áø·á½Ç¿¡ Àü´ÞÇÏ°í ´Ù½Ã Ã³¹æÀüÀ» ¹Þ¾Æ Á¶Á¦ÇÏ´Â ÀÏ·ÃÀÇ °úÁ¤ÀÌ ³×Æ®¿öÅ©·Î 󸮵ŠȯÀÚ´ë±â½Ã°£ÀÌ ´ëÆø ÁÙ°í, º°µµÀÇ Áø·á±â·Ï½ÇÀÌ ºÒÇÊ¿äÇÏ´Ù. |
||
| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
|---|---|
| CC | calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card... |
| ERIC | Educational Resource Information Center; Educational Resource Information Clearinghouse |
| CPS | carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ... |
| AIDSDRUGS | clinical trials of acquired immunodeficiency drugs [MEDLARS data base] |
| ACTG | AIDS Clinical Trials Group |
|---|---|
| CCTs | Controlled clinical trials |
| PACTG | Paediatric AIDS Clinical Trials Group |
| RCT | Randomized controlled clinical trials |
| JAMA | Journal of the American Medical Association |
edaphic factor
| clinical research trials | Evaluating the safety and effectiveness of medications or medical devices by monitoring their effects on large groups of people. Clinical medical trials sponsored by the U. S. Government are listed on a web site of the National Institutes of Health (NIH). The NIH Clinical Centre intends to make details of current clinical research studies for various diseases available over the Internet to increase opportunities for patients and physicians to participate in clinical investigations. (12 Dec 1998) |
|---|---|
| clinical trials | Medical research studies conducted with volunteers. Each study is designed to answer scientific questions and to find better ways to prevent, detect, or treat cancer. (12 Dec 1998) |
| clinical trials, phase I | Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase II | Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase III | Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| clinical trials, phase IV | Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the u.s. And in other countries. (12 Dec 1998) |
| controlled clinical trials | Clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterised as randomised controlled trials. However, trials employing treatment allocation methods such as coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes, are simply designated as controlled clinical trials. (12 Dec 1998) |
| online systems | Systems where the input data enter the computer directly from the point of origin (usually a terminal or workstation) and/or in which output data are transmitted directly to that terminal point of origin. (12 Dec 1998) |
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
| renewable energy resource | <ecology> An energy resource replenished continuously or that is replaced after use through natural means. Sustainable energy. Renewable energy resources include bioenergy, solar energy, wind energy, geothermal power, and hydropower. (25 Jun 1999) |
| resource | <chemistry> Total amount of a substance which exists in the earth and could conceivably be extracted someday at some price with some technology. Typically much larger than reserves. (10 Mar 1998) |
| resource conservation and recovery act | (RCRA) A federal law regulating solid and hazardous waste. RCRA governs the generation, storage, treatment, transport, and disposal of hazardous waste. (05 Dec 1998) |
| resource values | A resource, natural or social, that is found in an area. Resource values may have varying levels of significance. (05 Dec 1998) |
| integrated resource planning | See Least cost planning. (05 Dec 1998) |
| thermal resource | A facility that produces electricity by using a heat engine to power an electric generator. The heat may be supplied by the combustion of coal, oil, natural gas, biomass, or other fuels, including nuclear fission, solar, or geothermal resources. (05 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|